- Foreword
- Advisory Board
- Introduction - CCT
- Training and Education
Provided by CCT
- SFDA Inspection and Accreditation
- Ethics Committee
- Central Laboratories
- Clinical Trials Capabilities
 Cardiology
 Clinical Oncology
 Digestive and
 Liver Diseases
 Endocrinology
   Ophthalmology
   Phase I Studies Unit
   Paediatrics
   Anaesthesia and
 Intensive Care
   Community and
 Family Medicine
   Neurology
   Orthopedic and
 Traumatology
   Psychiatry
   Rheumatology
   Surgery
 
 

Clinical Trials Capabilities > Surgery

Urology Division

Strength and Expertise

  • Urolithiasis and extracorporeal shockwave lithotripsy
  • Minimal invasive surgery in urology
  • Uro-oncology
  • Andrology (erectile dysfunction and other)
  • Voiding dysfunction
  • Application of Traditional Chinese Medicine in urology

Special Facility and Equipment

  • On site lithotriptor
  • Robotic surgical suite

Disease Types and Number of Patients for Clinical Trials Recruitment

  • BPH / male voiding dysfunction – 400 new cases per year (a database of patients from 2005 till now ~ 700 cases)
  • Kidney tumour – 20 new cases per year
  • Prostate cancer – 50-70 new cases per year
  • Erectile dysfunction – around 200 new cases per year (with database of old cases around 500)
  • Stone disease – around 400 new cases per year

Collaboration, Partners and Multi-centre Trials Capability

Local research partners:

  • Prof PC Leung - Centre for Clinical Trial on Chine Medicine, Insititute of Chinese Medicine, CUHK
  • Prof D Gohel - Department of Health Technology and Informatics, The Hong Kong Polytechnic University

 

Neurosurgery

Strength and Expertise

  • Traumatic brain injury and brain monitoring
  • Functional neurosurgery
  • Pituitary and skull base surgery
  • Neurorehabilitation
  • Neuronavigation and virtual reality neurosurgery research
  • Brain tumour research
  • Subarachnoid haemorrhage and magnesium research
  • Cerebral blood flow research
  • Neural stem cell research

Special Facility and Equipment

  • Brain Tumour Center with laboratory and stem cell research setup
  • Brain monitoring including microdialysis, brain oxygenation and intraoperative blood flow measurement
  • Cerebral blood flow measurement with Xenon Computed Tomography

Disease Types and Number of Patients for Clinical Trials Recruitment

Our division had more than 2000 admissions and in-patient consultations every year and had outpatient consultations more than 5000 every year. We had a comprehensive spectrum of disease encounter and welcomed collaboration in different aspects of neurological diseases.

Collaboration, Partners and Multi-centre Trials Capability

  • 2007-2010: Surgical Trial in Lobar Intracerebral Haemorrhage (STICH II): A Study of the Treatment of Brain Haemorrhages.
  • 2006-2007: A Multi-Centre Clinical Study in Spinal Cord Injury Patients in Mainland China and Hong Kong.
  • 2002-2007: IMASH-Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage (Does Intravenous Magnesium Sulfate Improve Clinical Outcome?).
  • 1998-2002: Surgical Trial in Intracerebral Haemorrhage.

Clinical Trials Monitored and/or Audited by Industry, FDA and local RGC etc.

  • 2006-2010: A Registry for Comparing Catheter-Related Infection Rates among Various Shunt Systems in the Treatment of Hydrocephalus.
  • 2006-2009: Establishment of Baseline and Comparative Infection Rates for the Codman BACTISEALTM External Ventricular Drainage (EVD) System.
  • 2006-2007: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients with Acute Ischemic Stroke.

 

Plastic & Reconstruction Surgery

Strength and Expertise

  • Acute and reconstructive burns surgery.
  • Paediatric burns; epidemiology, prevention and outcomes of burns.
  • Laser therapy, surgery for benign and malignant skin lesions and general plastic surgery.
  • Reconstructive microsurgery particularly for head and neck cancer, breast cancer and soft tissue tumours.

Special Facility and Equipment

  • Burn Centre (comprehensive burn care is currently provided to 400 hospitalised patients per year in the 16-bed Burns Unit). Burns care is provided by a multidisciplinary burns team.
  • Skin and Laser Surgery Centre (cutaneous laser surgery for vascular and pigmented lesions as well as traumatic scars are currently delivered to over 1,000 outpatients per year).

Disease Types and Number of Patients for Clinical Trials Recruitment

  • For Trial (A), 100 Subjects with superficial or deep partial thickness burn, not exceeding 20 % Total Body Surface Area (TBSA), and not clinically infected were recruited over the 2 years period.
  • For Trial (B), patients with a complicated skin and skin structure infection will be enrolled.

Clinical Trials Monitored and/or Audited by Industry, FDA and local RGC etc.

  • Prospective, Randomized, Double Blind Controlled Trials of Hydrogel and Medicated Hydrogel in Acute Burns.
  • A Multicenter, Randomized, Open-Label Comparison of the Safety and Efficacy of Tigecycline with that of Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Complicated Skin and Skin Infections. (Wyeth Research)